Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts    Investorideas.com crypto corner    Play by Play – the latest sports headlines and sports stock news

 

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Leviathan Cannabis (CSE: EPIC) Debuts On The CSE 25 Index; #Cannabisstocks

Company Announces New Stock Option Grants

 

Toronto, Ontario - June 20, 2018 (Newsfile Corp.) (Investorideas.com Newswire) Leviathan Cannabis Group Inc. (CSE: EPIC) (the "Company" or "Leviathan") for the first time in its history, has been added to the CSE 25 Index at the close of trading on Friday, June 15, 2018. As a requirement for inclusion in the composite index, a company must fall within the top quartile of eligible securities listed on the CSE.

Martin J. Doane, CEO of Leviathan, comments, "It is a major accomplishment at our early stage of development and we appreciate the recognition from the CSE. Both the Board and Management at Leviathan are committed to building a unique, world class enterprise for our shareholders."

The CSE Composite Index is a broad indicator of market activity for the Canadian Securities Exchange. With approximately 75% coverage of all equities listed on the CSE, it is a uniquely positioned gauge of the Canadian small cap market. The index provides a distinctly different risk/return profile than the broad Canadian equity market.

Stock Option Grants

Leviathan also announces that the board of directors, on June 19, 2018, approved the granting of stock options to certain officers, directors and consultants exercisable for up to 3,000,000 Common Shares at $2.00 per share. The expiration date for this entire range of options is June 19, 2021.

About Leviathan Cannabis

Leviathan plans on executing a series of strategic acquisitions that extend across all vertical markets in Canada and internationally, to support the Company's proprietary brand strategy. This global reach positions the Company to be a leading multi-jurisdictional medical and recreational cannabis enterprise — one that brings together the best cannabis products, brands and expertise from Canada and around the world. The Leviathan portfolio currently comprises Jekyll+Hyde Brand Builders Inc., a ground-breaking marketing services agency specializing in the cannabis sector, and Woodstock Biomed Inc, a late stage applicant under the ACMPR, which is in the process of retrofitting a substantial greenhouse production facility in Pelham, Ontario.

Please visit
www.LeviathanCannabis.com
www.WeAreJekyllandHyde.com

For more information, contact:

Rick Rogers
Chairman
Leviathan Cannabis Group Inc.
416.303.9060

Jayne Beckwith
Interim CFO
Leviathan Cannabis Group Inc.
416.806.0591

Notice Regarding Forward Looking Information

Certain statements in this press release are "forward-looking" statements within the meaning of Canadian and United States securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. Forward-looking statements in this press release include, without limitation, that the Company intends to actively pursue acquisitions in Canada, in international markets and its intention to position the Company as a leading multi-jurisdictional medical and recreational cannabis enterprise. Forward-looking statements are generally, but not always, identified by the words "expects", "plans", "anticipates", "in the event", "if", "believes", "assets", "position", "intends", "envisages", "assumes", "recommends", "estimates", "approximate", "projects", "potential", "indicate" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements are necessarily based upon the current belief, opinions and expectations of management that, while considered reasonable by the Company, are inherently subject to significant litigation, business, economic, competitive, political and social uncertainties and other contingencies. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: identifying acquisitions; successfully negotiating a definitive agreement with an acquisition target; the conditions to the acquisition being satisfied or waived; finding partners to complete a transaction; and applicable board, shareholder, stock exchange, court and regulatory, approval of any proposed transaction.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.



Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

At Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news


More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp